INTRODUCTION
RIG-I-like helicases (RLHs), which include RIG-I (retinoic acidinducible gene I, DDX58), MDA-5 (melanoma differentiationassociated gene 5), and LGP2 (DHX58), are key cytosolic pattern-recognition receptors (PRRs) of the vertebrate innate immune system that form the first line of defense against infection by RNA viruses (Yoneyama et al., 2004) . PRRs are sensors of nonself microbe-associated molecular patterns (MAMPS), which in the case of RLHs are virus-specific RNA structures. Detection of viral RNA MAMPS by RIG-I activates the NF-kB and IRF3 signaling pathways, leading to interferon-b ( IFN-b) production. This in turn leads to the upregulation of numerous IFN-stimulated genes (ISGs), including RIG-I itself, that either directly combat the viral infection or mobilize other cells of the immune system (Gerlier and Lyles, 2011) . RIG-I is activated by diverse positive-and negative-stranded RNA viruses including influenza, rift valley, measles, vesicular stomatitis (VSV), and hepatitis C viruses (Loo and Gale, 2011) . Mice deficient in RIG-I are more susceptible to infection by RNA viruses , and the natural RIG-I deficiency of chickens may contribute to their high susceptibility to influenza virus (Barber et al., 2010; Karpala et al., 2011) .
RIG-I, a 925 residue, 106 kDa protein in human (hRIG-I), is highly conserved within vertebrates and comprises two N-terminal tandem caspase activation and recruitment domains (CARDs), a central DECH-box RNA helicase, and a C-terminal domain (CTD). MDA-5 has a similar architecture, whereas LGP2 lacks the CARDs. The RLHs form a subgroup of superfamily 2 (SF2) RNA helicases and are closely related to DEADbox helicases (Fairman-Williams et al., 2010) . They comprise N-and C-terminal RecA-like domains (denoted Hel1 and Hel2) that contain up to 12 conserved sequence motifs involved in nucleic acid and ATP binding and in ATP hydrolysis (Linder and Jankowsky, 2011) . RIG-I is thus a double-stranded RNA (dsRNA)-dependent ATPase (Gee et al., 2008) . The RIG-I subfamily includes Dicer, involved in the processing of small RNAs, as well as archaebacterial helicase-associated endonuclease for fork-structured DNA (Hef) (Nishino et al., 2005) and its vertebrate orthologs (Mosedale et al., 2005) . In uninfected cells, RIG-I is thought to be in an autorepressed conformation, with the CARDs unavailable for signal transduction. In vitro activation of RIG-I requires either an RNA that forms a bluntended, base-paired region of at least 18-20 nucleotides with a 5 0 triphosphate and free of mismatches near the blunt end (denoted 5 0 ppp-dsRNA [5 0 triphosphate double-stranded RNA]) (Marq et al., 2010; Schlee et al., 2009; Schmidt et al., 2009) or much longer (>200 bp) dsRNAs, including poly(I:C), not necessarily bearing a 5 0 ppp-end (Binder et al., 2011; Kato et al., 2008) . However, the nature and origin of the RNA species relevant for RIG-I activation in virally infected cells are unclear. Panhandle structures, which occur in many RNA virus systems and correspond to the blunt-end 5 0 ppp-dsRNA RIG-I MAMP (Schlee et al., 2009) , have been implicated, for instance, associated with viral genomic RNA or defective interfering particles in, respectively, influenza-or Sendai-infected cells (Baum et al., 2010; Rehwinkel et al., 2010; Strä hle et al., 2007) . RNA binding to RIG-I is mediated both by the CTD, which specifically binds the 5 0 triphosphate end, and by the helicase domain. The CTD, which contains a structural zinc ion, binds blunt-end 5 0 pppdsRNA with a 10-fold higher affinity compared to 5 0 OH-dsRNA Hornung et al., 2006; Lu et al., 2010; Pichlmair et al., 2006; Takahasi et al., 2008; Wang et al., 2010) . Viral RNA binding to RIG-I is thought to induce conformational changes that expose the CARDs, allowing E3-ligase tripartite motifcontaining 25 (TRIM25)-dependent K63 polyubiquitination of Lys172 (Gack et al., 2007) or endogenous K63-linked polyubiquitin chain binding (Zeng et al., 2010) . The polyubiquitinated CARDs then recruit the adaptor MAVS (mitochondrial antiviral signaling protein, also known as IPS-1/CARDIF/VISA) via CARD-CARD interactions (Kawai et al., 2005; Meylan et al., 2005; Seth et al., 2005; Xu et al., 2005) . Upon activation, MAVS aggregates in the outer mitochondrial membrane (Hou et al., 2011; Onoguchi et al., 2010) and, via a complex set of adapters and kinases (Belgnaoui et al., 2011) , activates the transcription factors IRF3, IRF7, AP1, and NF-kB that co-operatively coordinate the expression of type I IFN genes (Honda and Taniguchi, 2006) . Several additional protein-modifying enzymes and RNA-binding enhancers have been proposed to modulate the function of RIG-I (Wilkins and Gale, 2010; Yoneyama and Fujita, 2010) . Many RNA viruses have evolved mechanisms to counteract the RLH pathway (Bowie and Unterholzner, 2008) , including direct inhibition of RIG-I by Z protein of new world arenaviruses (Fan et al., 2010) , modulation of TRIM25-mediated polyubiquitination of RIG-I by NS1 of some influenza viruses (Gack et al., 2009; Kuo et al., 2010) , and inactivation by cleavage of MAVS by HCV protease .
Several mechanistic questions concerning the RIG-I activation pathway remain open, including the nature of the conformational changes and oligomerization state associated with viral RNA binding and the respective roles of ATP binding and hydrolysis. To resolve these issues, detailed structural information on the different states of RIG-I is essential. Although the crystal structure of RIG-I CTD bound to short 5 0 ppp-dsRNA has been determined (Lu et al., 2010; Wang et al., 2010) , neither the overall RIG-I architecture nor the atomic structure of any other domain, with or without bound RNA, is known. As our attempts to crystallize hRIG-I were unsuccessful, we turned to the homolog from the mallard duck Anas platyrhynchos (dRIG-I), which shares 53% sequence identity with hRIG-I (Data S1 available online). Transfection of dRIG-I into chicken cells (which naturally lack RIG-I or a RIG-I-like activity) (Karpala et al., 2011) enables them to respond to 5 0 ppp-RNA and activate interferon gene expression (Barber et al., 2010) . dRIG-I has in vitro dsRNA-dependent ATPase activity ( Figure S1A ) and was also found to elicit an antiviral state in chicken DF-1 cells in response to a 5 0 ppp leader RNA transcript from rabies virus ( Figure S1B ), indicating a likely similarity of the mechanisms of action of dRIG-I and hRIG-I. We crystallized and determined the structure of the following constructs of dRIG-I: the helicase domain alone (dRIG-I-Hel, 242-794) and in ternary complex with an ATP analog and an unphosphorylated 19-mer dsRNA (dRIG-I-Hel-ds19), dRIG-I-DCTD (1-794), and full-length dRIG-I (dRIG-I-FL, 1-933). These structures, together with previously published data, enable us to propose a detailed structure-based mechanism for RIG-I activation by viral RNA.
RESULTS AND DISCUSSION
Structure of Ligand-free RIG-I Helicase Domain The dRIG-I-Hel structure was determined at 3 Å resolution by the single anomalous diffraction method using seleno-methioninelabeled protein ( Figure S2A ). Ligand-free RIG-I helicase shows an open conformation in which the Hel1 (242-456) and Hel2 (458) (459) (460) (461) (462) (463) (464) (465) (466) (467) (468) (469) domains are not in direct contact, and several interstrand loops, particularly of Hel2, are disordered ( Figure 1 ). Secondary structure elements and helicase motifs are indicated in the RIG-I sequence alignment in Data S1. The C-terminal extension of Hel1 links to the outermost strand (b8) of Hel2 and then directly into an insertion domain (denoted Hel2i, residues 470-608), which is a bundle of five long, antiparallel a helices (a22-a26) ( Figure 1C) . Hef, the member of the RIG-I subfamily of helicases with the highest sequence homology to RLHs, has the same overall architecture as RIG-I ( Figure 1D ). The most striking feature of RIG-I helicase is an elbow-like helical structure that emerges from Hel2 and that will be referred to as the bridging domain (also named the pincer domain; see accompanying article by Luo et al. [2011; this issue of Cell] ). This comprises a long a helix (a31, 746-769) that bridges back to Hel1, with an 80 bend at conserved residue Trp772 leading into a second helix (a32, 774-793), which would connect to the CTD, absent from this construct (Figure 1 ). Extensive contacts are made by residues 761-789, either side of the bend, with residues on helices a19 and a20 and the following linker of Hel1. The proximal end of a31 has counterparts in other helicases (e.g., Hef, Figure 1D , and DPB5; see below), but the elbow structure bridging to the Hel1 domain is specific to RIG-I. Hel1-interacting residues E759, M762, Q770, K780, and Q785, some of which stabilize elements of the ATP-binding site (see below), are highly conserved, suggesting that the bridging domain is common to all RLH family members (Data S2).
Structures of the helicase in the context of the longer constructs dRIG-I-DCTD (1-794) and full-length dRIG-I (1-933) were also determined (see below). In all ligand-free structures, the helicase is in an open conformation with Hel2 and Hel2i forming a single rigid-body unit (Hel2i-Hel2 module). Between the five crystallographically different RIG-I molecules in three crystal forms, there is an angular span of about 30 in the orientation of the Hel1 domain after superposing the Hel2i-Hel2 module (Figure 1E ; Movie S1). The two hinge regions lie between residues 456 and 460 in the linker between Hel1 and b8 of Hel2 and 744-748 preceding the bridging helix a31. This highlights the intrinsic flexibility of the open form of the helicase, which probably contributes to the difficulty in crystallizing RIG-I.
Structure of dRIG-I Helicase Bound to a 19-mer dsRNA and ATP Analog Full-length RIG-I shows optimal RNA-dependent ATPase activity in the presence of 5 0 ppp-dsRNA, whereas RIG-I lacking the tandem CARDs (RIG-I-DCARDs) is equally active with 5 0 ppp-or 5 0 OH-dsRNA . Additionally, removing the CTD (i.e., RIG-I-Hel) significantly reduces ATPase activity , possibly due to reduced overall RNA-binding affinity. We succeeded in crystallizing dRIG-I-Hel with a blunt-ended 5 0 OH-dsRNA 19-mer in the presence of either the nonhydrolyzable ATP analog AMPPNP (monoclinic form, 4.2 Å resolution) or the transition state analog ADP-AlF 3 (tetragonal form, 3.7 Å resolution) ( Figure 2B ). Despite the modest resolution, the structure is well defined, with clear electron density for the ADP-AlF 3 -Mg ++ ( Figure S2B ) and the RNA ( Figure S2C ). In both crystal forms, the dsRNA forms pseudocontinuous A-form double helices throughout the crystal but with dislocations in the backbone between the 19-mers ( Figures 2C and S2C ). In the tetragonal form, crystallographically independent RIG-I molecules alternate along this pseudohelix without contacting each other, with an average spacing of 53 Å ( Figure 2C ). In the monoclinic crystal, the two independent RIG-I molecules form two distinct, parallel pseudocontinuous helices (not shown). Co-operative dsRNA and ATP binding results in a dramatic conformational change of the RIG-I helicase with all three subdomains (Hel1, Hel2i, and Hel2) moving relative to each other ( Figure 1F ; Movie S2). This brings the two RecA domains into intimate contact, creating the mature dsRNA-and ATP-binding sites (Figure 2) . Using Hel2 as reference, the Hel1 domain rotates by about 60 from its extreme position in the free helicase structures, and the Hel2i domain rotates 23 to form one wall of the dsRNAbinding groove. The configuration of Hel1, Hel2, and RNA thus becomes very similar to that observed for other RNA helicases bound to ATP and single-stranded RNA (ssRNA) (e.g., DPB5, Figure 2D ). Almost all the previously disordered loops from both RecA domains are now well defined and take part in RNA or ATP binding, in accordance with the canonical functions of the various conserved helicase motifs (Linder and Jankowsky, 2011) . Direct ADP-AlF 3 -Mg ++ binding involves residues from motif Q (Lys245 and Gln250 define the adenine specificity, Arg247 stacks on the adenine base), motif I (Walker A, 270-GxGKT), motif Ia (308-QQ), motif II (Walker B, 375-DE), motif Va (Gly704, Asp706-ribose), and motif VI (Gln727, Arg731, Arg733) ( Figure 2E ). As mentioned above, certain residues of the bridging helix a31, highly conserved in all RLH family members, are involved in stabilizing ATP-binding elements, e.g., Met762 interacts directly with motif III residues 414-VG, close to the site of ATP hydrolysis (Banroques et al., 2010) , and E759 makes a salt bridge to residue R729 (conserved across the RLH family) in ATP-binding motif VI ( Figure 2E ). A significant observation is that in all four crystallographically independent complexes (two in each crystal form), RIG-I helicase binds at one blunt-end extremity of the 19-mer dsRNA (Figure 2C ). Denoting 5 0 -GCAUGCGACCUCUGUUUGA as the 5 0 strand (with individual positions denoted 1, 2, 3..) and its complement, 3 0 -CGUACGCUGGAGACAAACU, as the 3 0 strand (with individual positions denoted 1*, 2*, 3*..) (Figure 2A ), the 3 0 strand backbone makes the most contacts with the helicase (Figures 2A  and 2D ). The backbone of the 3 0 extremity of the 3 0 strand (nucleotide 1*, Figure 2A ) is bound in a pocket involving interactions of Gly329 main-chain amide (motif Ib) and Thr350 (motif Ic) with the phosphate and Asn356 with the ribose. In the crystal structure, a second 19-mer is stacked against the 1*:1 blunt end, but the first base of this adjacent dsRNA (equivalent to 19*) is stacked over the center of the 1*:1 base pair, and there is a clear dislocation in the continuity of the backbone ( Figures 2C and S2C ). This suggests that the helicase preferentially binds a 3 0 end at this site. Phosphates 2*-4* of the 3 0 strand are bound via canonical motifs as observed in several ssRNA-binding helicases (e.g., DPB5, Figure 2D ) (Linder and Jankowsky, 2011) and frequently involve main-chain amide interactions. The phosphate of nucleotide 2* binds the main-chain amide of Val303 (motif Ia; mutation of the preceding residue in hRIG-I eliminates RNA binding) (Plumet et al., 2007) , that of 3* binds the main-chain amide of Thr698 (motif V; mutation of this conserved residue to alanine in hRIG-I eliminates dsRNA binding) (Bamming and Horvath, 2009) , the side chain of Arg638, and the main-chain amide of Gly663, and Motifs are defined in Data S1. Two conserved residues from the bridging helix a31 (red), which stabilize motifs III and VI, are also shown. In other helicases, such as Dpb5, analogous stabilization of motif VI occurs with residues from a C-terminal helix equivalent to the proximal part of the bridging helix a31, but motif III is stabilized by Hel1 elements, which take the same position as the distal end of the helix a31 in RIG-I. The corresponding Hel1 element in RIG-I (residues 442-456, i.e., b7 and a21) is consequently displaced. See also Data S1 and Figures S2 and S3.
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that of 4* binds the main-chain amide and side chain of Arg638 (motif IV). However, the following interactions, to both RNA strands, are unique to RIG-I and likely explain its preference for dsRNA. 3 0 strand nucleotides 6*, 7*, and 8* interact with Hel2i domain residues Glu511, His512, Val515, and Arg519 on helix a23. The 5 0 strand is recognized through contacts involving the backbones of nucleotides 4, 5, 8, and 9. Beyond nucleotides 8* and 9, neither strand makes any further contact with the RIG-I helicase. A particularly important interaction is that of the phosphate of nucleotide 5 with the main-chain amide of Asn383, immediately following the ATP-binding motif II (Walker B, . This asparagine is part of motif 383-NHPYNVIM and corresponds to 183-DHPYREIM in human Dicer (bold residues are highly conserved), suggesting that this is a conserved structural motif for binding a 5 0 chain phosphate in this subfamily of double-stranded nucleic acid-binding helicases (designated motif IIa in Figure 2A and Data S1). A functionally equivalent motif exists in SWI2/SNF2 ATPases that bind dsDNA (Dü rr et al., 2005) . 5 0 strand nucleotides 8 and 9 interact with Gln508 and Asn509 on helix a23 of the Hel2i domain. Note that most residues on helix a23 cited above (Gln508, Glu511, His512, Val515, and Arg519) are highly conserved or conservatively substituted in all known RIG-I sequences (Data S1). This region of Hel2i also interacts with the CARD2 in the RNA-free dRIG-I structures described below.
The crystal structure shows that the footprint of the RIG-I helicase domain on dsRNA is 9-10 bp. This, together with the apparent preference for 3 0 end dsRNA binding, even in the absence of the CTD, explains why the 19-mers used in crystallization only bind one RIG-I molecule at one end. Perhaps coincidentally, the arrangement of complexes in the crystal mimics the reported average density of 10-15 RIG-I molecules bound per 200 bp on long dsRNA (i.e., 35-52 Å apart) (Binder et al., 2011) . However, in neither crystal form do the RNA-bound RIG-I molecules dimerize through protein-protein interactions. Thus RNA binding per se does not induce multimerization of RIG-I. These observations are consistent with biophysical results showing that ligand-free dRIG-I and hRIG-I are both monomeric, and that binding a short (20 bp) 5 0 ppp-dsRNA gives a 1:1 complex whereas binding to longer (60 bp) 5 0 ppp-dsRNA results in an RNA-mediated 2:1 complex through binding of one RIG-I molecule to each end ( Figure S3 ).
The Structure and Intramolecular Interactions of the Tandem CARDs of RIG-I
The crystal structures of ligand-free RIG-I-DCTD (1-794) and fulllength dRIG-I-FL (1-933) reveal the structure and position of the tandem CARDs of RIG-I in the ligand-free state (Figures 3A and 3B) . Despite the moderate resolution, the electron density for the CARDs is good enough to fit side chains with confidence, aided by the seleno-methionine positions derived from anomalous difference data ( Figure S4A ). The structure of the tandem CARDs, an unusual duplication of a common signaling domain that occurs only in RIG-I, MDA-5, and NOD2, another cytosolic innate immune receptor (Fritz et al., 2006) , is shown in Figure 3C . Both domains (denoted CARD1 and CARD2) have the canonical CARD fold and superimpose with a root-mean-square deviation (rmsd) of 1.35 Å for 87 matched residues (15% identical). The C terminus of CARD1 links directly to the extended N-terminal helix (a8) of CARD2 ( Figure 3C ). The two CARDs thus form a head-to-tail unit, the transformation from the first to the second involving a rotation of 46
. There is intimate contact between the top (head) of CARD1 and the bottom (tail) of the CARD2, involving both hydrophobic and polar interactions. The CARD1-CARD2 interface is mediated by residues highly conserved in all RIG-Is, notably Tyr24, Tyr81, Ile130, and the peptide 159-RSDK (Data S1; Figure S4B ). The structure strongly suggests that the tandem CARDs form an essentially rigid functional unit, consistent with the fact that only the intact double domain is capable of signaling (Zeng et al., 2010) .
In all four crystallographically independent molecules in the RIG-I-DCTD structure and the two in the RIG-I-FL structure, the tandem CARDs are identically bound to the insertion domain (Hel2i) of the helicase ( Figures 3B and 3D ). Although the 55 residue linker between CARD2 and Hel1 is invisible in the electron density due to disorder, the monomeric state of free RIG-I ( Figure S3 ) indicates that the CARDs most likely bind to the Hel2i domain of the same molecule, rather than being swapped between monomers. Three segments (residues 106-114, 143-150, and 176-185) at the top end of CARD2 interface with helices a23, a24, and a25 of Hel2i, burying a substantial solventexposed surface totaling 1971 Å 2 ( Figure S4C ). The interface includes a number of putative salt bridges (e.g., Arg537-Glu110, Lys548-Glu115, Arg519-Glu183, Arg522-Asp186) as well as significant hydrophobic contacts. Most of the implicated residues are conserved or conservatively substituted in all RIG-Is, e.g., the key hydrophobic interactions are made by Ile109 and Leu184 in the CARDs and Phe540 and Phe571 in Hel2i (equivalent residues in hRIG-I: Leu110, Leu185, Phe539, and Phe570) (Data S1; Figure S4C ). CARD2's extensive contact with the Hel2i domain, its proximity to the Hel1 domain, and possibly the excluded volume of the CARD2-Hel1 linker would sterically hinder its interactions with other macromolecules, notably K63-linked polyubiquitin or the ubiquitin ligase machinery. In contrast, the CARD1 surface, apart from that binding CARD2, is solvent accessible ( Figure 3D ).
Full-length dRIG-I (1-933) crystallizes in a different space group than RIG-I-DCTD (1-794), yet the determined structures are very similar due to the absence of any electron density for the additional CTD in the full-length crystals. However, the last bridging helix visible (a32) leads into an ''empty'' crystal volume that could accommodate the CTD. The presence of the zinccontaining CTD in the crystals is confirmed by a clear zinc absorption edge signal, and gel analysis of crystals shows fulllength protein (data not shown). This suggests that in the RNAfree state, the CTD is flexibly linked to the rest of the protein and has no strong interaction with it, as confirmed by pulldown experiments with purified CTD.
Implications for the Functions of the Tandem CARDs
In the current model of hRIG-I activation, the tandem CARDs are proposed to play an important role in autorepression and signaling (Gack et al., 2008; Meylan et al., 2005; Saito et al., 2007; Zeng et al., 2010) . Intact tandem CARDs (minimally residues 1-190) (Zeng et al., 2010) are necessary and sufficient for signaling, whereas RIG-I-DCARDs (Saito et al., 2007 ) and a human splice variant with residues 36-80 deleted from CARD1 (Gack et al., 2008) are dominant negative. Upon RIG-I binding to an RNA agonist, CARD1 is thought to become available for interaction with the E3 ubiquitin ligase TRIM25 via its PRYSPRY domain (Gack et al., 2007) . This interaction is inhibited by the mutation Thr55Ile (Gack et al., 2008) , which confers permissivity to hepatitis C virus infection by blocking RIG-I signaling (Sumpter et al., 2005) . Binding of TRIM25 leads to K63-linked polyubiquitination of Lys172 on CARD2 (Gack et al., 2007) , a covalent modification that enhances the CARD-CARD interaction of RIG-I with the downstream adaptor protein MAVS (Gack et al., 2008) . In an alternative scenario, downstream signaling via MAVS requires the binding of unanchored K63-linked polyubiquitin chains generated by TRIM25 to the hRIG-I CARDs, the binding implicating the same residues Thr55 and Lys172 (Hou et al., 2011; Zeng et al., 2010 ). Yet other authors have questioned the importance of Lys172 for RIG-I signaling (Shigemoto et al., 2009 ), except that the linker between CARD1 and CARD2 is in straw. CARD1 (residues 1-91) and CARD2 (residues 100-186) are structurally most similar to, respectively, the CARD of APAF1 (PDB 1CY5, Dali z score = 14.9, 21% identical) and the CARD of MAVS (PDB 2VGQ, Dali z score = 13.3, 17% identical). The positions of some functionally important residues in the CARDs that are discussed in the text are shown in orange: Ser8 (conserved in hRIG-I), Ala55 (T55 in hRIG-I), and Gln170 (Lys172 in hRIG-I).
(D) Orthogonal surface diagrams of the dRIG-I DCTD structure showing tandem CARDs with CARD2 (blue) forming a large interface with Hel2i (yellow). In the right-hand diagram, the residues 186 (end of CARD2) and 245 (beginning of Hel1), which are spatially separated by 42 Å , are indicated in black. The 58 residue linker connecting these residues, disordered in the crystal structure, is represented by a dotted black oval. See also Figure S4 .
dRIG-I, it is unknown whether signaling is polyubiquitin dependent or not. In birds and mouse, Lys172 is substituted by a glutamine (Gln170 in dRIG-I, Data S1), which clearly cannot be covalently polyubiquitinated, but this may not be relevant if only polyubiquitin binding is necessary. In any case, due to the high sequence conservation among RIG-Is, the dRIG-I tandem CARDs likely represent the equivalent hRIG-I structure well enough to interpret published results on hRIG-I. The side chain of Gln170 (Lys172 in hRIG-I) is close and possibly interacting with the C-terminal extremity of CARD2 (residue 186, before the 55 residue long, flexible linker to the helicase domain) ( Figures 3C and 3D ) and is also very close to CARD2's interface with Hel2i. Thus, in the inactive conformation, there is probably significant steric hindrance to polyubiquitination or polyubiquitin binding at this site, due to either the large size of the polyubiquitination machinery (Gack et al., 2009) or the space required by the flexible linear K63-linked polyubiquitin chains (Datta et al., 2009 ). Thr55 in hRIG-I, thought to interact with the TRIM25 PRYSPRY domain, corresponds to Ala54 in dRIG-I, which is a solvent-exposed residue on helix a8 in the center of one face of CARD1 ( Figure 3C ). However, little is known about the mode of interaction of hRIG-I CARDS with either the TRIM25 PRYSPRY domain or the CARD of MAVS. The latter interaction may involve multiple CARDs from several RIG-I and MAVS molecules, as observed in other death-domain complexes (Kersse et al., 2011; Lin et al., 2010) , as well as K63-linked polyubiquitin. Finally, it has been reported that the phosphorylation of Ser8 residue negatively regulates hRIG-I apparently by preventing TRIM25 binding Nistal-Villá n et al., 2010) . Ser8 is conserved in dRIG-I where it is solvent exposed ( Figure 3C ) and thus accessible to a kinase that may possibly stabilize the autorepression state of RIG-I.
Structural Model for 5
0 ppp-dsRNA Binding to the Helicase and CTD The apparent preferential binding of dRIG-I helicase to the 3 0 end of a short dsRNA led us to ask whether this was structurally compatible with the known mode of binding of a blunt-end 5 0 ppp-dsRNA to the CTD of RIG-I. First we solved the structures of the dRIG-I CTD alone (residues 806-933, 1.44 Å resolution) and in complex with a 14-mer blunt-end 5 0 OH-dsRNA (4 Å resolution). As expected, these structures are very similar to the corresponding published hRIG-I CTD structures (Lu et See also Figure S5 . Wang et al., 2010) and confirm that for dRIG-I, the loop 849-857 changes conformation upon dsRNA binding, allowing Phe855 to stack on the blunt-end bases ( Figure S5 ). We then superposed the blunt-end dsRNA from the dRIG-I CTD-dsRNA complex on that of the helicase-dsRNA complex, as both are essentially regular A-form RNA. Remarkably, after superposition, there is no significant clash between the CTD and the helicase ( Figure 4B ), and the protein encircles and caps the blunt-end dsRNA extremity (Figures 4D and 4E ). Most significantly, there is perfect complementarity between the binding modes of the helicase and CTD to the blunt-end dsRNA. Whereas the helicase interacts mainly with the 3 0 strand, the CTD interacts mainly with the 5 0 extremity, including the triphosphate (Lu et al., 2010; Wang et al., 2010) (Figure 4C ). The pattern of recognition suggests that RIG-I would be less tolerant of mismatches perturbing the canonical A-form backbone conformation within the first 4-5 bp from the blunt end, as reported (Schlee et al., 2009) . Furthermore, the observed end of the helicase domain (residue 793) and the beginning of the CTD (residue 807) are both on the same side of the molecule and orientated toward each other (the 14 residue linker would have to span 30 Å , Figure 4D ). According to this model, there could be a contact between the CTD in the region of residue 869 and a24 at the extremity of the insertion domain. In addition, the only remaining poorly ordered loop in the Hel2 domain (residues 667-673 lack electron density) is in a suitable position to interact with and possibly stabilize the critical RNA-binding loop containing Phe855, mentioned above (observed residue 666 is very close to the modeled position of CTD residue 851). Taken together, these observations suggest that our model of the binding of 5 0 pppdsRNA to RIG-I is highly plausible.
The Autorepressed State
The structures of the full-length and DCTD dRIG-I suggest that free RIG-I exists in an open state with the tandem CARDs bound to the helicase insertion domain and with the CTD flexibly linked to the helicase ( Figure 4F ). How does this conformation repress signaling? In early work, the ''repressor/regulatory domain'' (RD) was identified as a region spanning residues 735-925 of hRIG-I with dominant-negative activity in signaling and thus presumed to maintain RIG-I in an autorepressed state (Saito et al., 2007) . Subsequently, this construct was found to poorly behave in vitro (which can now be understood because residues 735-925 comprise strand b13 from Hel2, the bridging domain, and the CTD), and the RD was redefined as the soluble and well-folded triphosphate-binding CTD (residues 802-925 or 792-925 [Takahasi et al., 2008] ). The major mechanism through which the isolated CTD inhibits RIG-I activation was found to be competition with native RIG-I for 5 0 pppdsRNA binding . That the CTD is not directly involved in autorepression is further supported by its lack of binding to the helicase in vitro ( Figure 5A ). On the other hand, considerable evidence favors a crucial role of the CARDs in maintaining the nonsignaling, ligand-free state with concomitant inhibition of the dsRNA-dependent ATPase activity, presumably by masking an RNA-binding site on the helicase domain Gee et al., 2008) . These observations are now rationalized by our structures of 1-794 and 1-933, which both show binding of the CARDs to the Hel2i domain in a way that partially overlaps with the dsRNA-binding site (Figure 4F) . Indeed, if our model for the CTD position in the activated state is correct, then not only part of the bound dsRNA but also the entire CTD would clash with CARD2 ( Figure 4F ). In support of this scenario, we show biochemically in vitro for dRIG-I that the isolated CARDs, but not the isolated CTD, pull down the helicase domain, and the CARDs-helicase interaction is eliminated by either addition of dsRNA (which competes with the CARDs for binding to the helicase) or use of the 1-794 construct (in which CARDs are already bound to the helicase in cis) ( Figure 5A ). Furthermore, our model predicts that disruption of the binding of the CARDs to the Hel2i domain should result in constitutively active RIG-I. Indeed, when the conserved interface residue Phe540 in dRIG-I ( Figure S4C ) is substituted by alanine or aspartic acid, mutated dRIG-I, despite being poorly expressed, exhibits a constitutively active phenotype in chicken DF-1 cells. This is revealed by a significant enhancement of the expression of Mx1 (an IFN-induced gene in chicken) over the wild-type (WT) dRIG-I background ( Figures 5B, 5C , and 5E). Likewise, these dRIG-I mutants and their human counterparts F539A and F539D display constitutive activity in stimulating the human IFN-b promoter in human Huh7.5 cells (in which hRIG-I is disabled) despite very low expression of the former ( Figures 5B, 5D , and 5E). Notably, the F > D substitution consistently confers a higher constitutive RIG-I activity than F > A, despite systematically lower expression, presumably because it is more effective in disrupting the CARD2-Hel2i interface. Structure-Based Functional Model for RIG-I Activation by Short 5 0 pppdsRNA Figure 6 and Movie S3 show our structurebased model for RIG-I activation by short (20-40 bp) blunt-end 5 0 ppp-dsRNA. In the ligand-free, autorepressed state, the helicase is in an open and flexible state with low affinity for ATP and dsRNA ( Figure 6A ). In this state, binding of CARD2 to the helicase insertion domain, and possibly the presence of the long CARD2-helicase linker, sterically hinders not only dsRNA binding to the helicase but also access of ubiquitination enzymes and covalent or noncovalent binding of polyubiquitin, thus inhibiting signaling via MAVS. In contrast, the CTD is flexibly linked to the helicase without strong interactions with the rest of the protein. Thus the CTD remains available for sensing and capturing 5 0 ppp-dsRNA as the first step in activation of RIG-I thanks to its significantly higher affinity (10-fold) and longer off-rate (327 s compared to 28 s) for 5 0 ppp-dsRNA compared to 5 0 OH-dsRNA (Lu et al., 2010) (Figure 6B ). Initial, long-lifetime binding to the CTD increases the local concentration of dsRNA in the vicinity of the helicase, favoring the co-operative binding of ATP and dsRNA and inducing the high ligand affinity, closed form of the helicase. The associated conformational switch forces the release of the tandem CARDs, the continued binding of which is sterically incompatible with tight dsRNA binding to the helicase and the repositioned CTD ( Figure 6C) . Release of the CARDs on a 55 residue long, flexible linker makes them freely accessible for K63-linked polyubiquitination or polyubiquitin binding (Figure 6D) . However, the state depicted in Figure 6C will not have a long lifetime as it is competent for ATP hydrolysis; thus until polyubiquitination happens, cycling between states 6B and 6C could occur without necessarily full disassociation of the RNA but with consumption of ATP. After polyubiquitination, downstream signaling via MAVS can finally occur. Indeed, as long as the CARDs stay polyubiquitinated, for steric reasons they cannot be rebound to the helicase to reconstitute the autorepressed state even after ATP hydrolysis opens the helicase and potentially remain available for signaling until deubiquitinated ( Figure 6E ). We emphasize that the above mechanism is for short (20-40 bp) blunt-end 5 0 ppp-dsRNA. However, RIG-I can also be activated by long (>200 bp) dsRNAs without triphosphate ends (Binder et al., 2011) , although the existence of such RNAs in infected cells is controversial, particularly for negative-strand ssRNA viruses (Gerlier and Lyles, 2011; Schlee et al., 2009) . A possible explanation is that RIG-I helicase domain might be capable of internal binding on dsRNA without requiring a 5 0 ppp blunt end but almost certainly with much lower affinity because the CTD cannot be engaged, and this may be sufficient to displace the CARDS.
Concluding Remarks
The crystal structures presented here allow us to propose a detailed structure-based mechanism for RIG-I activation consistent with many prior observations. Indeed we show that RIG-I is optimized to bind panhandle-like blunt-end 5 0 ppp-dsRNA, the currently accepted RIG-I MAMP, and in doing so releases the CARDs for signaling. Furthermore, the structures provide rich information that can be exploited to further refine our understanding of the RIG-I mechanism. A clear priority is to verify by direct structure determination the model for 5 0 ppp-dsRNA binding to the combined helicase and CTD. Other outstanding questions to be investigated include the structural basis for the interaction of RIG-I with MAVS (Belgnaoui et al., 2011; Hou et al., 2011) and clarification of the step(s) at which ATP hydrolysis is important and its consequences, together with (de)-polyubiquitination for the duration of signaling competence and recycling or degradation. Many of the structural features described here will be common to the homologous RLHs, MDA-5, and LGP2. The most striking sequence differences between hMDA-5 and hRIG-I are the significantly longer linker between CARD2 and the helicase (105 compared to 55 residues) and, in the helicase insertion domain, the shortening of a22 and a24 and the insertion of an acidic stretch between a25 and a26 (Data S2). These differences could affect the CARD interactions with the helicase in the autorepressed state as well as the competition with dsRNA for binding and might ultimately explain the still obscure mechanistic differences between MDA-5 and RIG-I. Beyond this, our RIG-I structures give insight into the whole RIG-I-like dsRNA/DNA-binding subfamily of SF2 helicases, including helicase containing Dicers. Finally these studies further highlight and give insight into the diverse biological functions of helicases (Linder and Jankowsky, 2011) , revealing structural details showing how an innate immune pattern-recognition receptor that is also a DECH helicase couples 5 0 -triphosphorylated base-paired RNA and ATP binding to enable interferon signaling.
EXPERIMENTAL PROCEDURES Expression and Purification of RIG-I Constructs
Constructs comprising residues 1-933, 1-794, and 242-794 of Anas platyrhynchos RIG-I (accession number ACA61272) were cloned from a synthetic gene into pFastBAC and expressed in HiFive insect cells following standard procedures. Protein extracted from lysed cells was purified on a Nickel NTA column via a 6-histidine tag, which was then cleaved with TEV protease. Cleaved protein was repurified on Nickel-NTA and by size-exclusion chromatography. Seleno-methionine-labeled protein was produced in HiFive cells adapted to ESF921 methionine-free medium. dRIG-I CTD (806-933) and CARDs (1-210) were expressed in E. coli from a PET11 vector in BL21* cells.
Crystallization and Structure Determination
Protein crystals were grown in sitting or hanging drops by mixing protein and reservoir solution in a 1:1 ratio. Crystallization conditions are given in the Extended Experimental Procedures. Glycerol cryoprotected crystals were flash frozen in liquid nitrogen and exposed on beamline ID14-4 at the European Synchrotron Radiation Facility (ESRF), Grenoble, France. Diffraction data and refinement statistics are given in Table 1 . dRIG-I helicase structure was determined by the SAD method using seleno-methionine-labeled protein. Subsequent structures were determined by molecular replacement. dRIG-I CTD was solved using zinc SAD.
Functional Analysis of dRIG-I and hRIG-I
The abilities of WT and F540/F539 mutants of dRIG-I and hRIG-I to activate the innate immune response were tested in chicken DF-1 (without endogenous RIG-I) and/or human Huh7.5 cells (with endogenous inactive T55I hRIG-I mutant). Cells seeded the day before were transfected with RIG-I expression vectors supplemented or not with pcIFN-b-luc and followed 1 day later by transfection of rabies leader as 5 0 ppp-RNA agonist. The day after, the human IFN-b promoter activation and chicken Mx1 gene transcription levels were measured using a luciferase assay and RT-qPCR, respectively. RIG-I protein expression was determined by western blot of cell extracts.
ACCESSION NUMBERS
The PDB accession codes for coordinates and structure factors are 4a2p (dRIG-I helicase alone), 4a36 (dRIG-I helicase with 19-mer dsRNA and ADPAlF 3 ), 4a2q (dRIG-I CARDs and helicase), 4a2w (full-length dRIG-I), 4a2v (dRIG-I CTD), and 4a2x (dRIG-I CTD with 14-mer dsRNA).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, five figures, two data files, and three movies and can be found with this article online at doi:10.1016/j.cell.2011.09.039.
